Mohr Davidow Ventures is a California-based venture capital firm investing across diverse sectors including information technology, life sciences, pharmaceuticals, finance, advertising, software, and healthcare. The firm typically focuses on early-stage investments, with a strong presence in Series A and B rounds, though they also participate in later stages.
Notable portfolio companies include 23andMe, Kabbage, Pacific Biosciences, and Coupa Software. Mohr Davidow Ventures emphasizes a hands-on approach, providing extensive support and expertise to their portfolio companies beyond initial funding. Their investment philosophy centers on identifying transformative technologies and supporting entrepreneurs throughout their growth journey.
Mohr Davidow Ventures - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Total Investments146
Current Portfolio Count44
Total Portfolio Exits6
Top Investment Stages
Series A34 (30.1%)
Series B28 (24.8%)
Series C21 (18.6%)
Seed16 (14.2%)
Series Unknown14 (12.4%)
Stage Mix
Series A 30%Series B 25%Series C 19%Seed 14%Series Unknown 12%
Concentration shown as share of disclosed investments by stage.
Mohr Davidow Ventures - Classification
- NAICS
- 520000Finance and Insurance
- 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
- 523900Other Financial Investment Activities
- 523990All Other Financial Investment Activities
- 523999Miscellaneous Financial Investment Activities
- SIC
- 6700Holding And Other Investment Offices
- 6790Miscellaneous Investing
- 6799Investors, Not Elsewhere Classified
Show 6 more industry codes
- NAICS
- 525000Funds, Trusts, and Other Financial Vehicles
- 523910Miscellaneous Intermediation
- 523940Portfolio Management and Investment Advice
- SIC
- 6000Depository Institutions
- 6720Investment Offices
- 6722Management Investment Offices, Open-end